The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma
Anand G. Patel, Xiang Chen, Xin Huang, Michael R. Clay, Natalia L. Komarova, Matthew J. Krasin, Alberto S. Pappo, Heather Tillman, Brent A. Orr, Justina McEvoy, Brittney Gordon, Kaley Blankenship, Colleen Reilly, Xin Zhou, Jacqueline L. Norrie, Åsa Karlström, Jiyang Yu, Dominik Wodarz, Elizabeth Stewart, Michael A. Dyer
Topics & Concepts
BiologyRhabdomyosarcomaMyogenesisParaxial mesodermCancer researchPopulationMesodermPAX3Internal medicineBioinformaticsOncologyGeneticsMyocyteEndocrinologyPathologySarcomaEmbryonic stem cellTranscription factorMedicineGeneEnvironmental healthCAR-T cell therapy researchSarcoma Diagnosis and TreatmentSingle-cell and spatial transcriptomics